Professor Paul Hofman
Nice Sophia Antipolis University, France
Evaluating Tumor Mutational Burden with NGS
10 Jun 2019
In this video, Prof. Paul Hofman outlines how his team use the Oncomine Tumor Mutation Load (TML) Assay from Thermo Fisher Scientific for benchtop next-generation sequencing (NGS) when evaluating tumour mutational burden (TMB).
LIKE
0
Featured technology
Related Scientists
-
Cell AnalysisDr. Jeanette Woolard Faculty of Medicine & Health Sciences, The University of Nottingham -
-
-
-
-
-
Cell AnalysisDr. Kirk McManus Department of Biochemistry and Medical Genetics, University of Manitoba -
-sm.jpg)
-
Cell AnalysisEli Bar, PhD Department of Neurological Surgery, Case Western Reserve University, Ohio -
-
-
-
-
-
Cell AnalysisProf. Stephen Hill Faculty of Medicine & Health Sciences, The University of Nottingham Medical School
Related Content
